{"id":15879,"date":"2014-02-24T10:59:34","date_gmt":"2014-02-24T15:59:34","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=15879"},"modified":"2014-02-24T10:59:34","modified_gmt":"2014-02-24T15:59:34","slug":"marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879","title":{"rendered":"Marina Biotech Inc (OTCMKTS:MRNA) Declares $6 Million Convertible Preferred Stock Financing"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 02\/24\/2014 (wallstreetpr) &#8211; <b>Marina Biotech Inc (OTCMKTS:MRNA) <\/b>announced entering into a binding term sheet with biotechnology investors led by Steven T. Newby. It will issue convertible preferred stock at an exchange price equivalent to $0.75 a share of common stock which would fetch it $6 million.<\/p>\n<p style=\"text-align: justify;\"><b>Marina Biotech\u2019s Announcements<\/b><\/p>\n<p style=\"text-align: justify;\">Marina Biotech Inc (OTCMKTS:MRNA) is a leader in oligonucleotide based drug discovery and is a development company which focuses on rare diseases. The company today has announced its binding term sheet with Newby who is a long time investor in biotechnology. Apart from this, the company also plans to issue warrants to the investors to buy 6 million shares of the common stock. The warrants will be issued at an exercise cost of $0.75 a share and could be implemented for five years after the company recovers compliance with its reporting mandates under the Securities Exchange Act.<\/p>\n<p style=\"text-align: justify;\">The offering is anticipated to come to a close in March on or by the 7<sup>th<\/sup>, which depends on the carrying out of the customary Securities Purchase Agreement concerning the transaction and the approval of customary closing terms.<\/p>\n<p style=\"text-align: justify;\">Marina Biotech Inc (OTCMKTS:MRNA) further announced that the holders of its Promissory Note have consented with converting the rest of the principal and interest on the Note to common stock at an exchange price of $0.75 and have also agreed to release their lien on its intellectual property. Marina Biotech said that the proceeds from the financing, which will be around $6million, will be used in restarting some of its everyday operations, repay its outstanding obligations, and recuperate compliance with the Company\u2019s Exchange Act reporting duty and take forward its preclinical and clinical rare diseases agenda.<\/p>\n<p style=\"text-align: justify;\">Marina Biotech Inc (OTCMKTS:MRNA)\u2019s President and Chief Executive Officer, J. Michael French believes the investment to be of great importance as it would take his company in a new direction, led by the knowledgeable investor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 02\/24\/2014 (wallstreetpr) &#8211; Marina Biotech Inc (OTCMKTS:MRNA) announced entering into a binding term sheet with biotechnology investors led by Steven T. Newby. It [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":15881,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[4710,4711],"stock_ticker":[],"class_list":["post-15879","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-marina-biotech-inc-otcmktsmrna","tag-otcmktsmrna","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Marina Biotech Inc (OTCMKTS:MRNA) Declares $6 Million Convertible Preferred Stock Financing - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Marina Biotech Inc (OTCMKTS:MRNA) Declares $6 Million Convertible Preferred Stock Financing - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 02\/24\/2014 (wallstreetpr) &#8211; Marina Biotech Inc (OTCMKTS:MRNA) announced entering into a binding term sheet with biotechnology investors led by Steven T. Newby. It [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-02-24T15:59:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Marina-Biotech-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"297\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Marina Biotech Inc (OTCMKTS:MRNA) Declares $6 Million Convertible Preferred Stock Financing\",\"datePublished\":\"2014-02-24T15:59:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879\"},\"wordCount\":329,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Marina-Biotech-Inc.jpg\",\"keywords\":[\"Marina Biotech Inc (OTCMKTS:MRNA)\",\"OTCMKTS:MRNA\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879\",\"name\":\"Marina Biotech Inc (OTCMKTS:MRNA) Declares $6 Million Convertible Preferred Stock Financing - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Marina-Biotech-Inc.jpg\",\"datePublished\":\"2014-02-24T15:59:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Marina-Biotech-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Marina-Biotech-Inc.jpg\",\"width\":1024,\"height\":297},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Marina Biotech Inc (OTCMKTS:MRNA) Declares $6 Million Convertible Preferred Stock Financing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marina Biotech Inc (OTCMKTS:MRNA) Declares $6 Million Convertible Preferred Stock Financing - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879","og_locale":"en_US","og_type":"article","og_title":"Marina Biotech Inc (OTCMKTS:MRNA) Declares $6 Million Convertible Preferred Stock Financing - Wall Street PR","og_description":"Boston, MA 02\/24\/2014 (wallstreetpr) &#8211; Marina Biotech Inc (OTCMKTS:MRNA) announced entering into a binding term sheet with biotechnology investors led by Steven T. Newby. It [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-02-24T15:59:34+00:00","og_image":[{"width":1024,"height":297,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Marina-Biotech-Inc.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Marina Biotech Inc (OTCMKTS:MRNA) Declares $6 Million Convertible Preferred Stock Financing","datePublished":"2014-02-24T15:59:34+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879"},"wordCount":329,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Marina-Biotech-Inc.jpg","keywords":["Marina Biotech Inc (OTCMKTS:MRNA)","OTCMKTS:MRNA"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879","url":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879","name":"Marina Biotech Inc (OTCMKTS:MRNA) Declares $6 Million Convertible Preferred Stock Financing - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Marina-Biotech-Inc.jpg","datePublished":"2014-02-24T15:59:34+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Marina-Biotech-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Marina-Biotech-Inc.jpg","width":1024,"height":297},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/marina-biotech-inc-otcmktsmrna-declares-6-million-convertible-preferred-stock-financing-15879#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Marina Biotech Inc (OTCMKTS:MRNA) Declares $6 Million Convertible Preferred Stock Financing"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/15879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=15879"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/15879\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/15881"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=15879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=15879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=15879"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=15879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}